Life Threatening Idiopathic Recurrent Angioedema Responding to Cannabis
Open Access
- 16 July 2015
- journal article
- case report
- Published by Hindawi Limited in Case Reports in Immunology
- Vol. 2015, 1-3
Abstract
We present a case of a 27-year-old man with recurrent episodes of angioedema since he was 19, who responded well to treatment with medical grade cannabis. Initially, he responded to steroids and antihistamines, but several attempts to withdraw treatment resulted in recurrence. In the last few months before prescribing cannabis, the frequency and severity of the attacks worsened and included several presyncope events, associated with scrotal and neck swelling. No predisposing factors were identified, and extensive workup was negative. The patient reported that he was periodically using cannabis socially and that during these periods he was free of attacks. Recent data suggest that cannabis derivatives are involved in the control of mast cell activation. Consequently, we decided to try a course of inhaled cannabis as modulators of immune cell functions. The use of inhaled cannabis resulted in a complete response, and he has been free of symptoms for 2 years. An attempt to withhold the inhaled cannabis led to a recurrent attack within a week, and resuming cannabis maintained the remission, suggesting a cause and effect relationship. We present a case of a 27-year-old man with recurrent episodes of angioedema since he was 19, who responded well to treatment with medical grade cannabis. Initially, he responded to steroids and antihistamines, but several attempts to withdraw treatment resulted in recurrence. In the last few months before prescribing cannabis, the frequency and severity of the attacks worsened and included several presyncope events, associated with scrotal and neck swelling. No predisposing factors were identified, and extensive workup was negative. The patient reported that he was periodically using cannabis socially and that during these periods he was free of attacks. Recent data suggest that cannabis derivatives are involved in the control of mast cell activation. Consequently, we decided to try a course of inhaled cannabis as modulators of immune cell functions. The use of inhaled cannabis resulted in a complete response, and he has been free of symptoms for 2 years. An attempt to withhold the inhaled cannabis led to a recurrent attack within a week, and resuming cannabis maintained the remission, suggesting a cause and effect relationship.Keywords
This publication has 10 references indexed in Scilit:
- Cannabinoid Receptor 2: Potential Role in Immunomodulation and NeuroinflammationJournal of Neuroimmune Pharmacology, 2013
- Diagnosis and Treatment of Urticaria and Angioedema: A Worldwide PerspectiveWorld Allergy Organization Journal, 2012
- Cannabinoids and Innate Immunity: Taking a Toll on NeuroinflammationThe Scientific World Journal, 2011
- Nonallergic angioedema: role of bradykininAllergy, 2007
- Cannabinoids for the treatment of inflammation.2007
- Angioedema without urticaria: a large clinical surveyCanadian Medical Association Journal, 2006
- AngioedemaJournal of the American Academy of Dermatology, 2005
- The cannabinoid system and immune modulationJournal of Leukocyte Biology, 2003
- Blockade of Effects of Smoked Marijuana by the CB1-Selective Cannabinoid Receptor Antagonist SR141716Archives of General Psychiatry, 2001
- URTICARIA AND ANGIO-OEDEMA.British Journal of Dermatology, 1969